Acasti Pharma Inc.
ACST
$0.06
Change (1 day)
$3.59
Year High
$1.98
Year Low
Categories
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Earnings for Acasti Pharma Inc. (ACST)
Earnings in 2023 (TTM): $-14,630,000
According to Acasti Pharma Inc.'s latest financial reports the company's current earnings (TTM) are $-14,630,000. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Acasti Pharma Inc.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $-14,630,000 | $-12,853,000 |
| 2022 | $-51,971,000 | $-42,429,000 |
| 2021 | $-10,467,000 | $-9,819,000 |
| 2020 | $-19,678,000 | $-19,678,000 |
| 2019 | $-25,513,000 | $-25,760,000 |
| 2018 | $-38,620,431 | $-43,861,594 |
| 2017 | $-16,651,567 | $-16,942,722 |
| 2016 | $ | $ |
| 2015 | $-4,661,416 | $-4,661,416 |
| 2014 | $-1,322,541 | $-1,322,541 |
| 2013 | $-10,435,936 | $-10,435,936 |
| 2012 | $-6,732,464 | $-6,732,464 |
| 2011 | $-6,538,661 | $-6,538,661 |
| 2010 | $ | $-2,426,846 |
| 2009 | $-1,527,334 | $-1,508,303 |